A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma
Dong-A ST Co., Ltd.
Dong-A ST Co., Ltd.
Yonsei University
Qilu Pharmaceutical Co., Ltd.
Pusan National University Yangsan Hospital
Convalife (Shanghai) Co., Ltd.
Xijing Hospital of Digestive Diseases
Fudan University
Hebei Medical University
Hebei Medical University
The First Affiliated Hospital with Nanjing Medical University
Pfizer
Vanderbilt-Ingram Cancer Center
Sichuan University
Swansea Bay University Health Board
Onconic Therapeutics Inc.
Qilu Pharmaceutical Co., Ltd.
The First Affiliated Hospital with Nanjing Medical University
Second Life Therapeutics
The First Affiliated Hospital with Nanjing Medical University
Beijing Friendship Hospital
Shanghai Zhongshan Hospital
Yonsei University
Nantes University Hospital
Fujian Medical University
LanZhou University
The First Affiliated Hospital with Nanjing Medical University
LanZhou University